Novita Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 21
Rang # Quantité totale PI 70 341
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 084
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

12 1
5 0
3 0
0
 
Dernier brevet 2024 - Methods for inhibiting fascin
Premier brevet 2013 - Methods for inhibiting fascin
Dernière marque 2024 - PRILUKAE
Première marque 2024 - PRILUKAE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the treatment of cancer.
2023 Invention Methods for inhibiting fascin. Provided are compositions and methods for treating a condition or...
Invention Compounds and methods for inhibiting fascin. Provided are compounds, compositions and methods for...
Invention Co-therapies including a metastasis inhibitor. Provided are methods of increasing a response to ...
2021 Invention Methods for inhibiting fascin. Provided are compositions and methods for treating a condition or ...
2018 Invention Co-therapies including a metastasis inhibitor. Provided are methods of increasing a response to a...
Invention Co-therapies including a metastasis inhibitor. The present invention relates to pharmaceutical co...
2015 Invention Substituted indazol-3-yl derivatives and pharmaceutical compositions thereof useful as inhibitor ...
2013 Invention Methods for inhibiting fascin. Provided are uses of a compound of Formula III: or a tautomer, and...